Dr. Puzanov on T-VEC in Combination with Ipilimumab for Melanoma Treatment

http://youtu.be/3lzK3fonzns Igor Puzanov, MD, medical oncologist, Vanderbilt-Ingram Cancer Center, discusses the rationale behind a phase 1b study to evaluate the efficacy and safety of T-VEC and ipilimumab in previously untreated, unresected stage IIIB-IV melanoma.